EGFR and non-small cell lung carcinoma: A larger study of 40 EGFR-mutated advanced NSCLC patients compared the incidence of the T790M EGFR mutation in tumor samples (n=40), CTCs (isolated by CTC-chip) (n=28), and ctDNA (n=32) [144].